Skip to main content
Hauptrubriken
CME Facharzt-Training Webinare Zeitschriften Bücher e.Medpedia Podcast
Service
Jobbörse Info & Hilfe
Fachgebiete
Anästhesiologie Allgemeinmedizin Arbeitsmedizin Augenheilkunde Chirurgie Dermatologie Gynäkologie und Geburtshilfe HNO Innere Medizin Kardiologie Neurologie Onkologie und Hämatologie Orthopädie und Unfallchirurgie Pädiatrie Pathologie Psychiatrie Radiologie Rechtsmedizin Urologie Zahnmedizin
Themen
Klimawandel und Gesundheit Neues aus dem Markt COVID-19 Praxis und Beruf Seltene Erkrankungen GOÄ & EBM Panorama
Sammlungen
Kasuistiken Algorithmen & Infografiken Blickdiagnosen Arthropedia FlapFinder (für Dermatochirurgen) Videos Kongressberichterstattung Medizin für Apothekerinnen und Apotheker Für Ärztinnen und Ärzte in Weiterbildung Für Medizinstudierende

Live-Webinar: Aktuelle Leitlinien bei Herz-Kreislauf-Erkrankungen

Konkret geht es um den Diabetes-Patienten mit kardiovaskulären Erkrankungen oder Risiken, die Herzinsuffizienz sowie die kardiovaskuläre Primär- und Sekundärprävention. Sind Sie hier schon auf dem neuesten Stand? Unsere Experten beleuchten, wo und warum das bisherige Procedere geändert werden soll und was in der Praxis sinnvoll ist. Holen Sie sich Ihr Update und 2 CME-Punkte beim MMW-Webinar am 24. April von 17.30 bis 19 Uhr. 
Erweiterte Suche
Anmelden
nach oben
Neurological Sciences
Erschienen in: Neurological Sciences 3/2021

11.01.2021 | COVID-19 | COVID-19 Zur Zeit gratis

Neurological manifestations of coronavirus disease 2019: exploring past to understand present

verfasst von: Ishita Desai, Rajat Manchanda, Niraj Kumar, Ashutosh Tiwari, Mritunjai Kumar

Erschienen in: Neurological Sciences | Ausgabe 3/2021

Einloggen, um Zugang zu erhalten

Abstract

SARS-CoV-2 infection, resulting in Coronavirus disease 2019 (COVID-19), has significantly affected the entire world. It was labelled a pandemic by World Health Organization. Although it commonly produces respiratory symptoms, neurological features have been described. Neurological manifestations may vary from non-specific symptoms such as headache, dizziness, myalgia and/or fatigue, olfactory or taste dysfunction to specific syndromes including meningitis, stroke, acute transverse myelitis and Guillain-Barre syndrome. This review describes potential pathogenetic mechanisms and neurological manifestations of COVID-19 along with its management. Considering structural and pathogenetic similarity of SARS-CoV-2 with SARS-CoV and MERS viruses, we compared their neurological manifestations and mentioned few features expected in COVID-19 in future. Interestingly, many COVID-19 cases may present with pure neurological manifestations at onset with non-neurological features manifesting few days later and we propose the term “Neuro-COVID syndrome” for such cases. Awareness of neurological manifestations may facilitate its management and improve outcome in such patients.
Literatur
1.
Galassi G, Marchioni A (2020) Facing acute neuromuscular diseases during COVID-19 pandemic: focus on Guillain–Barré syndrome. Acta Neurol Belg [Internet] 120(5):1067–1075PubMedPubMedCentralCrossRef
2.
Xie M, Chen Q (2020) Insight into 2019 novel coronavirus — an updated interim review and lessons from SARS-CoV and MERS-CoV. Int J Infect Dis [Internet] 94:119–124PubMedPubMedCentralCrossRef
3.
Jin Y, Yang H, Ji W, Wu W, Chen S, Zhang W et al (2020) Virology, epidemiology, pathogenesis, and control of COVID-19. Viruses [Internet] 12(4):1–17CrossRef
4.
Zubair AS, McAlpine LS, Gardin T, Farhadian S, Kuruvilla DE, Spudich S (2020) Neuropathogenesis and neurologic manifestations of the coronaviruses in the age of coronavirus disease 2019: a review. JAMA Neurol 77(8):1018–1027PubMedPubMedCentralCrossRef
5.
6.
Vonck K, Garrez I, De Herdt V, Hemelsoet D, Laureys G, Raedt R et al (2020) Neurological manifestations and neuro-invasive mechanisms of the severe acute respiratory syndrome coronavirus type 2. Eur J Neurol 27(8):1578–1587PubMedCrossRef
7.
Coolen T, Lolli V, Sadeghi N, Rovai A, Trotta N, Taccone FS et al (2020) Early postmortem brain MRI findings in COVID-19 non-survivors. Neurology 95(14):e2016–e2027PubMedCrossRef
8.
Karimi-Galougahi M, Yousefi-Koma A, Bakhshayeshkaram M, Raad N, Haseli S (2020) 18FDG PET/CT scan reveals hypoactive orbitofrontal cortex in anosmia of COVID-19. Acad Radiol 27(7):1042–1043PubMedPubMedCentralCrossRef
9.
Xu XW, Wu XX, Jiang XG, Xu KJ, Ying LJ, Ma CL et al (2020) Clinical findings in a group of patients infected with the 2019 novel coronavirus (SARS-Cov-2) outside of Wuhan, China: Retrospective case series. BMJ 368(January):1–7
10.
Borges do Nascimento IJ, Cacic N, Abdulazeem HM, von Groote TC, Jayarajah U, Weerasekara I et al (2020) Novel coronavirus infection (COVID-19) in humans: a scoping review and meta-analysis. J Clin Med 9(4):941PubMedCentralCrossRef
11.
Mao L, Jin H, Wang M, Hu Y, Chen S, He Q et al (2020) Neurologic manifestations of hospitalized patients with coronavirus disease 2019 in Wuhan, China. JAMA Neurol [Internet] 77(6):683PubMedCrossRef
12.
Metlay JP, Waterer GW, Long AC, Anzueto A, Brozek J, Crothers K, Cooley LA, Dean NC, Fine MJ, Flanders SA, Griffin MR, Metersky ML, Musher DM, Restrepo MI, Whitney CG (2019) Diagnosis and treatment of adults with community-acquired pneumonia. Am J Respir Crit Care Med 200(7):E45–E67PubMedPubMedCentralCrossRef
13.
Morfopoulou S, Brown JR, Davies EG, Anderson G, Virasami A, Qasim W, Chong WK, Hubank M, Plagnol V, Desforges M, Jacques TS, Talbot PJ, Breuer J (2016) Human coronavirus OC43 associated with fatal encephalitis. N Engl J Med 375(5):497–498PubMedCrossRef
14.
Jacomy H, Fragoso G, Almazan G, Mushynski WE, Talbot PJ (2006) Human coronavirus OC43 infection induces chronic encephalitis leading to disabilities in BALB/C mice. Virology. 349(2):335–346PubMedCrossRef
15.
Kim JE, Heo JH, Kim HO, Song SH, Park SS, Park TH, Ahn JY, Kim MK, Choi JP (2017) Neurological complications during treatment of middle east respiratory syndrome. J Clin Neurol 13(3):227–233PubMedPubMedCentralCrossRef
16.
Poyiadji N, Shahin G, Noujaim D, Stone M, Patel S, Griffith B (2020) COVID-19–associated acute hemorrhagic necrotizing encephalopathy: CT and MRI features. Radiology [Internet] 5(564):201187
17.
Dixon L, Varley J, Gontsarova A, Mallon D, Tona F, Muir D et al (2020) COVID-19-related acute necrotizing encephalopathy with brain stem involvement in a patient with aplastic anemia. Neurol Neuroimmunol Neuroinflamm 7(5):1–8CrossRef
18.
Moriguchi T, Harii N, Goto J, Harada D, Sugawara H, Takamino J et al (2020) A first case of meningitis/encephalitis associated with SARS-Coronavirus-2. Int J Infect Dis [Internet] 94:55–58PubMedPubMedCentralCrossRef
19.
Zhou L, Zhang M, Wang J, Gao J (2020) Sars-Cov-2: Underestimated damage to nervous system. Travel Med Infect Dis [Internet] 36(January):101642
20.
Etemadifar M, Salari M, Murgai AA, Hajiahmadi S (2020) Fulminant encephalitis as a sole manifestation of COVID-19. Neurol Sci [Internet] 41(11):3027–3029PubMedCrossRef
21.
Duong L, Xu P, Liu A (2020) Meningoencephalitis without respiratory failure in a young female patient with COVID-19 infection in Downtown Los Angeles, early April 2020. Brain Behav Immun 87:33PubMedPubMedCentralCrossRef
22.
Wong PF, Craik S, Newman P, Makan A, Srinivasan K, Crawford E, Dev D, Moudgil H, Ahmad N (2020) Lessons of the month 1: A case of rhombencephalitis as a rare complication of acute COVID-19 infection. Clin Med 20(3):293–294CrossRef
23.
Umapathi T, Kor AC, Venketasubramanian N, Lim CCT, Pang BC, Yeo TT, Lee CC, Lim PL, Ponnudurai K, Chuah KL, Tan PH, Tai DYH, Ang SPB (2004) Large artery ischaemic stroke in severe acute respiratory syndrome (SARS). J Neurol 251(10):1227–1231PubMedPubMedCentralCrossRef
24.
Fatima N, Saqqur M, Qamar F, Shaukat S, Shuaib A (2020) Impact of COVID-19 on neurological manifestations: an overview of stroke presentation in pandemic. Neurol Sci 41(10):2675–2679PubMedCrossRef
25.
Sharifi-Razavi A, Karimi N, Rouhani N (2020) COVID-19 and intracerebral haemorrhage: causative or coincidental? New Microbes New Infect 35:100669PubMedPubMedCentralCrossRef
26.
Al Saiegh F, Ghosh R, Leibold A, Avery MB, Schmidt RF, Theofanis T et al (2020) Status of SARS-CoV-2 in cerebrospinal fluid of patients with COVID-19 and stroke. J Neurol Neurosurg Psychiatry 91(8):846–848PubMedCrossRef
27.
Hughes C, Nichols T, Pike M, Subbe C, Elghenzai S (2020) Cerebral venous sinus thrombosis as a presentation of COVID-19. Eur J Case Rep Intern Med 7(5):1691
28.
Klein DE, Libman R, Kirsch C, Arora R (2020) Cerebral venous thrombosis: atypical presentation of COVID-19 in the young. J Stroke Cerebrovasc Dis [Internet] 29(8):104989PubMedPubMedCentralCrossRef
29.
Dakay K, Cooper J, Bloomfield J, Overby P, Mayer SA, Nuoman R et al (2020) Cerebral venous sinus thrombosis in COVID-19 infection: a case series and review of the literature. J Stroke Cerebrovasc Dis 30(1):105434PubMedPubMedCentralCrossRef
30.
Gómez-Enjuto S, Hernando-Requejo V, Lapeña-Motilva J, Ogando-Durán G, Fouz-Ruiz D, Domingo-García J, Rodríguez-García E, Cemillán-Fernández CA (2020) Verapamil as treatment for refractory status epilepticus secondary to PRES syndrome on a SARS-Cov-2 infected patient. Seizure [Internet] 80(January):157–8
31.
Kishfy L, Casasola M, Banankhah P, Parvez A, Jan YJ, Shenoy AM et al (2020) Posterior reversible encephalopathy syndrome (PRES) as a neurological association in severe Covid-19. J Neurol Sci [Internet] 414(January):116943
32.
Parauda SC, Gao V, Gewirtz AN, Parikh NS, Merkler AE, Lantos J et al (2020) Posterior reversible encephalopathy syndrome in patients with COVID-19. J Neurol Sci [Internet] 416:117019PubMedPubMedCentralCrossRef
33.
Kaya Y, Kara S, Akinci C, Kocaman AS (2020) Transient cortical blindness in COVID-19 pneumonia; a PRES-like syndrome: case report. J Neurol Sci [Internet] 413(January):116858
34.
Saitta L, Molin A, Villani F, Insorsi A, Roccatagliata L, Inglese M et al (2020) Brain microvascular occlusive disorder in COVID-19: a case report. Neurol Sci 41:3401–3404PubMedPubMedCentralCrossRef
35.
Boucher A, Desforges M, Duquette P, Talbot PJ (2007) Long-term human coronavirus-myelin cross-reactive T-cell clones derived from multiple sclerosis patients. Clin Immunol 123(3):258–267PubMedPubMedCentralCrossRef
36.
37.
Stewart JN, Mounir S, Talbot PJ (1992) Human coronavirus gene expression in the brains of multiple sclerosis patients. Virology. 191(1):502–505PubMedCrossRef
38.
Pilotto A, Odolini S, Stefano Masciocchi S, Comelli A, Volonghi I, Gazzina S et al (2020) Steroid-responsive encephalitis in Covid-19 disease. Ann Neurol 2:1–5
39.
Zanin L, Saraceno G, Panciani PP, Renisi G, Signorini L, Migliorati K et al (2020) SARS-CoV-2 can induce brain and spine demyelinating lesions. Acta Neurochir 162(7):1491–1494PubMedCrossRef
40.
AlKetbi R, AlNuaimi D, AlMulla M, AlTalai N, Samir M, Kumar N (2020) Acute myelitis as a neurological complication of Covid-19: a case report and MRI findings. Radiol Case Rep 15(9):1591–1595PubMedPubMedCentralCrossRef
41.
42.
Munz M, Wessendorf S, Koretsis G, Tewald F, Baegi R, Krämer S et al (2020) Acute transverse myelitis after COVID-19 pneumonia. J Neurol 267(8):2196–2197PubMedPubMedCentralCrossRef
43.
Sarma D, Bilello LA (2020) A case report of acute transverse myelitis following novel coronavirus infection. Clin Pract Cases Emerg Med 4(3):321–323PubMedPubMedCentralCrossRef
44.
Panariello A, Bassetti R, Radice A, Rossotti R, Puoti M, Corradin M et al (2020) Anti-NMDA receptor encephalitis in a psychiatric Covid-19 patient: a case report. Brain Behav Immun 87:179–181PubMedPubMedCentralCrossRef
45.
Rábano-Suárez P, Bermejo-Guerrero L, Méndez-Guerrero A, Parra-Serrano J, Toledo-Alfocea D, Sánchez-Tejerina D et al (2020) Generalized myoclonus in COVID-19. Neurology 95(6):e767–e772PubMedPubMedCentralCrossRef
46.
Borroni B, Gazzina S, Dono F, Mazzoleni V, Liberini P, Carrarini C, Russo M, Pontolillo M, Vecchiet J, Onofrj M, Bonanni L (2020) Diaphragmatic myoclonus due to SARS-CoV-2 infection. Neurol Sci [Internet] 41(12):3471–3474PubMedPubMedCentralCrossRef
47.
Wright D, Rowley R, Halks-Wellstead P, Anderson T, Wu TY (2020) Abnormal saccadic oscillations associated with severe acute respiratory syndrome coronavirus 2 encephalopathy and ataxia. Mov Disord Clin Pract 7(8):980–982PubMedPubMedCentralCrossRef
48.
49.
50.
Cohen ME, Eichel R, Steiner-Birmanns B, Janah A, Ioshpa M, Bar-Shalom R, Paul JJ, Gaber H, Skrahina V, Bornstein NM, Yahalom G (2020) A case of probable Parkinson’s disease after SARS-CoV-2 infection. Lancet Neurol [Internet] 19(10):804–805PubMedPubMedCentralCrossRef
51.
Chen N, Zhou M, Dong X, Qu J, Gong F, Han Y, Qiu Y, Wang J, Liu Y, Wei Y, Xia J', Yu T, Zhang X, Zhang L (2020) Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. Lancet [Internet] 395(10223):507–513PubMedPubMedCentralCrossRef
52.
Klopfenstein T, Kadiane-Oussou NJ, Toko L, Royer PY, Lepiller Q, Gendrin V et al (2020) Features of anosmia in COVID-19. Med Mal Infect 50(5):436–439PubMedPubMedCentralCrossRef
53.
Helms J, Kremer S, Merdji H, Clere-Jehl R, Schenck M, Kummerlen C et al (2020) Neurologic features in severe SARS-CoV-2 infection. N Engl J Med 382(23):2268–2270PubMedCrossRef
54.
Dono F, Carrarini C, Russo M, De Angelis MV, Anzellotti F, Onofrj M et al (2020) New-onset refractory status epilepticus (NORSE) in post SARS-CoV-2 autoimmune encephalitis: a case report. Neurol Sci 3:1–4
55.
Vaira LA, Salzano G, Deiana G, De Riu G (2020) Anosmia and ageusia: common findings in COVID-19 patients. Laryngoscope 130(7):1787PubMedCrossRef
56.
Bagheri SHR, Asghari AM, Farhadi M, Shamshiri AR, Kabir A, Kamrava SK et al (2020) Coincidence of COVID-19 epidemic and olfactory dysfunction outbreak in Iran. Med J Islam Repub Iran 34:62PubMedPubMedCentral
57.
Lechien JR, Chiesa-Estomba CM, De Siati DR, Horoi M, Le Bon SD, Rodriguez A et al (2020) Olfactory and gustatory dysfunctions as a clinical presentation of mild-to-moderate forms of the coronavirus disease (COVID-19): a multicenter European study. Eur Arch Otorhinolaryngol 277(8):2251–2261PubMedPubMedCentralCrossRef
58.
59.
Cabañes-Martínez L, Villadóniga M, González-Rodríguez L, Araque L, Díaz-Cid A, Ruz-Caracuel I, Pian H, Sánchez-Alonso S, Fanjul S, del Álamo M, Regidor I (2020) Neuromuscular involvement in COVID-19 critically ill patients. Clin Neurophysiol [Internet] 131(12):2809–2816PubMedPubMedCentralCrossRef
60.
Huber M, Rogozinski S, Puppe W, Framme C, Höglinger G, Hufendiek K et al (2020) Postinfectious onset of myasthenia gravis in a COVID-19 patient. Front Neurol 11(October):1–5
61.
Belvis R (2020) Headaches during COVID-19: my clinical case and review of the literature. Headache 60(7):1422–1426PubMedCrossRef
62.
Benameur K, Agarwal A, Auld SC, Butters MP, Webster AS, Ozturk T, Howell JC, Bassit LC, Velasquez A, Schinazi RF, Mullins ME, Hu WT (2020) Encephalopathy and encephalitis associated with cerebrospinal fluid cytokine alterations and coronavirus disease, Atlanta, Georgia, USA, 2020. Emerg Infect Dis [Internet] 26(9):2016–2021PubMedPubMedCentralCrossRef
63.
Trigo López J, García-Azorín D, Planchuelo-Gómez Á, García-Iglesias C, Dueñas-Gutiérrez C, Guerrero ÁL (2020) Phenotypic characterization of acute headache attributed to SARS-CoV-2: an ICHD-3 validation study on 106 hospitalized patients. Cephalalgia [Internet] 40(13):1432–1442CrossRef
64.
Caronna E, Ballvé A, Llauradó A, Gallardo VJ, María Ariton D, Lallana S et al (2020) Headache: A striking prodromal and persistent symptom, predictive of COVID-19 clinical evolution. Cephalalgia. 40(13):1410–1421PubMedPubMedCentralCrossRef
65.
Ferrando SJ, Klepacz L, Lynch S, Tavakkoli M, Dornbush R, Baharani R et al (2020) COVID-19 Psychosis: A potential new neuropsychiatric condition triggered by novel coronavirus infection and the inflammatory response? Psychosomatics 61(5):551–555PubMedPubMedCentralCrossRef
66.
67.
Beyrouti R, Adams ME, Benjamin L, Cohen H, Farmer SF, Goh YY et al (2020) Characteristics of ischaemic stroke associated with COVID-19. J Neurol Neurosurg Psychiatry 0(0):8–11
68.
69.
Grau AJ, Buggle F, Becher H, Zimmermann E, Spiel M, Fent T, Maiwald M, Werle E, Zorn M, Hengel H, Hacke W (1998) Recent bacterial and viral infection is a risk factor for cerebrovascular ischemia. Clinical and biochemical studies. Neurology. 50(1):196–203PubMedCrossRef
70.
Tang N, Li D, Wang X, Sun Z (2020) Abnormal coagulation parameters are associated with poor prognosis in patients with novel coronavirus pneumonia. J Thromb Haemost 18(4):844–847PubMedPubMedCentralCrossRef
71.
Ellul MA, Benjamin L, Singh B, Lant S, Michael BD, Easton A, Kneen R, Defres S, Sejvar J, Solomon T (2020) Neurological associations of COVID-19. Lancet Neurol [Internet] 19(9):767–783PubMedPubMedCentralCrossRef
72.
Zhang Y, Xiao M, Zhang S, Xia P, Cao W, Jiang W et al (2020) Coagulopathy and antiphospholipid antibodies in patients with Covid-19. N Engl J Med [Internet] 382(17):e38PubMedCrossRef
73.
Doo FX, Kassim G, Lefton DR, Patterson S, Pham H, Belani P (2021) Rare presentations of COVID-19: PRES-like leukoencephalopathy and carotid thrombosis. Clin Imaging [Internet] 69(January):94–101
74.
Filatov A, Sharma P, Hindi F, Espinosa PS (2020) Neurological complications of coronavirus disease (COVID-19): encephalopathy. Cureus 2(3):e7352
75.
Vollono C, Rollo E, Romozzi M, Frisullo G, Servidei S, Borghetti A, Calabresi P (2020) Focal status epilepticus as unique clinical feature of COVID-19: a case report. Seizure [Internet] 78:109–112PubMedPubMedCentralCrossRef
76.
Nemoto W, Yamagata R, Nakagawasai O, Nakagawa K, Hung WY, Fujita M et al (2020) Effect of spinal angiotensin-converting enzyme 2 activation on the formalin-induced nociceptive response in mice. Eur J Pharmacol [Internet] 872(July 2019):172950
77.
Diezma-Martín AM, Morales-Casado MI, García-Alvarado N, Vadillo Bermejo A, López-Ariztegui N, Sepúlveda Berrocal MA (2020) Temblor y ataxia en COVID-19. Neurología [Internet] 35(6):409–410PubMedPubMedCentralCrossRef
78.
Schellekens MMI, Bleeker-Rovers CP, Keurlings PAJ, Mummery CJ, Bloem BR (2020) Reversible myoclonus-ataxia as a postinfectious manifestation of COVID-19. Mov Disord Clin Pract 7(8):977–979PubMedPubMedCentralCrossRef
79.
Steardo L, Steardo L, Zorec R, Verkhratsky A (2020) Neuroinfection may contribute to pathophysiology and clinical manifestations of COVID-19. Acta Physiol (Oxf) 229(3):e13473CrossRef
80.
Wei H, Yin H, Huang M, Guo Z (2020) The 2019 novel cornoavirus pneumonia with onset of oculomotor nerve palsy: a case study. J Neurol [Internet] 267(5):1550–1553PubMedCrossRef
81.
Zito A, Alfonsi E, Franciotta D, Todisco M, Gastaldi M, Cotta Ramusino M et al (2020) COVID-19 and Guillain–Barré syndrome: a case report and review of literature. Front Neurol [Internet] 11(August):1–7
82.
Suwanwongse K, Shabarek N (2020) Rhabdomyolysis as a presentation of 2019 novel coronavirus disease. Cureus [Internet] 12(4):10–13
83.
84.
85.
Medicherla CB, Pauley RA, de Havenon A, Yaghi S, Ishida K, Torres JL (2020) Cerebral venous sinus thrombosis in the coronavirus disease 2019 pandemic. J Neuroophthalmol Publish Ah:457–462CrossRef
86.
Gigli GL, Vogrig A, Nilo A, Fabris M, Biasotto A, Curcio F, Miotti V, Tascini C, Valente M (2020) HLA and immunological features of SARS-CoV-2-induced Guillain-Barré syndrome. Neurol Sci 41(12):3391–3394PubMedPubMedCentralCrossRef
87.
Pilato MS, Urban A, Alkawadri R, Barot N V., Castellano JF, Rajasekaran V et al (2020) EEG findings in coronavirus disease. J Clin Neurophysiol [Internet] Publish Ah(00):1–7
88.
Kassardjian CD, Desai U, Narayanaswami P (2020) Practical guidance for managing EMG requests and testing during the COVID-19 pandemic. Muscle Nerve 62:30–33PubMedCrossRef
89.
Sanders JM, Monogue ML, Jodlowski TZ, Cutrell JB (2020) Pharmacologic treatments for coronavirus disease 2019 (COVID-19): a review. JAMA 323(18):1824–1836PubMed
90.
Thachil J, Tang N, Gando S, Falanga A, Cattaneo M, Levi M et al (2020) ISTH interim guidance on recognition and management of coagulopathy in COVID-19. J Thromb Haemost 8(5):1023–1026CrossRef
91.
Manji H, Carr AS, Brownlee WJ, Lunn MP (2020) Neurology in the time of COVID-19. J Neurol Neurosurg Psychiatry [Internet] 91(6):568–570PubMedCrossRef
Metadaten
Titel
Neurological manifestations of coronavirus disease 2019: exploring past to understand present
verfasst von
Ishita Desai
Rajat Manchanda
Niraj Kumar
Ashutosh Tiwari
Mritunjai Kumar
Publikationsdatum
11.01.2021
Verlag
Springer International Publishing
Schlagwort
COVID-19
Erschienen in
Neurological Sciences / Ausgabe 3/2021
Print ISSN: 1590-1874
Elektronische ISSN: 1590-3478
DOI
https://doi.org/10.1007/s10072-020-04964-8

Weitere Artikel der Ausgabe 3/2021

Neurological Sciences 3/2021 Zur Ausgabe

Original Article

An online, interactive, screen-based simulator for learning basic EEG interpretation

Letter to the Editor

Marchiafava–Bignami disease–like corpus callosum lesions due to moyamoya disease

Letter to the Editor

Segmental dystonia after radical neck dissection and radiotherapy: a case report

Letter to the Editor

Intrathecal cytosine arabinoside-induced progression of chronic methotrexate myelopathy

COVID-19

The impact of lockdown during SARS-CoV-2 outbreak on behavioral and psychological symptoms of dementia

Review Article

Multidisciplinary care in Amyotrophic Lateral Sclerosis: a systematic review and meta-analysis

Leitlinien kompakt für die Neurologie

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Kostenlos registrieren

Neu im Fachgebiet Neurologie

18.04.2024 | Arterielle Hypertonie | Nachrichten

Antihypertensiva schützen auch alte Menschen noch vor Demenz

18.04.2024 | Spinale Muskelatrophien | Nachrichten

Spinale Muskelatrophie: Neugeborenen-Screening lohnt sich

16.04.2024 | Maligne primäre ZNS-Tumoren | Nachrichten

Manche Gestagene können das Risiko für Meningeome erhöhen

15.04.2024 | Parkinson-Krankheit | Nachrichten

Parkinson: Größere Studie bestätigt Genauigkeit von Hauttest
weitere anzeigen

Update Neurologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen
Bildnachweise